171 related articles for article (PubMed ID: 1455322)
1. Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery.
Icard P; Chapuis Y; Andreassian B; Bernard A; Proye C
Surgery; 1992 Dec; 112(6):972-9; discussion 979-80. PubMed ID: 1455322
[TBL] [Abstract][Full Text] [Related]
2. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group.
Icard P; Goudet P; Charpenay C; Andreassian B; Carnaille B; Chapuis Y; Cougard P; Henry JF; Proye C
World J Surg; 2001 Jul; 25(7):891-7. PubMed ID: 11572030
[TBL] [Abstract][Full Text] [Related]
3. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy.
Luton JP; Cerdas S; Billaud L; Thomas G; Guilhaume B; Bertagna X; Laudat MH; Louvel A; Chapuis Y; Blondeau P
N Engl J Med; 1990 Apr; 322(17):1195-201. PubMed ID: 2325710
[TBL] [Abstract][Full Text] [Related]
4. Adrenocortical carcinoma. Our experience.
Favia G; Lumachi F; Carraro P; D'Amico DF
Minerva Endocrinol; 1995 Mar; 20(1):95-9. PubMed ID: 7651289
[TBL] [Abstract][Full Text] [Related]
5. Adrenocortical carcinoma: Retrospective analysis of the last 22 years.
Guelho D; Paiva I; Vieira A; Carrilho F
Endocrinol Nutr; 2016 May; 63(5):212-9. PubMed ID: 26969077
[TBL] [Abstract][Full Text] [Related]
6. The long-term survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane.
Wängberg B; Khorram-Manesh A; Jansson S; Nilsson B; Nilsson O; Jakobsson CE; Lindstedt S; Odén A; Ahlman H
Endocr Relat Cancer; 2010 Mar; 17(1):265-72. PubMed ID: 20026647
[TBL] [Abstract][Full Text] [Related]
7. Surgical management, DNA content, and patient survival in adrenal cortical carcinoma.
Lee JE; Berger DH; el-Naggar AK; Hickey RC; Vassilopoulou-Sellin R; Gagel RF; Burgess MA; Evans DB
Surgery; 1995 Dec; 118(6):1090-8. PubMed ID: 7491528
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant mitotane treatment for adrenocortical carcinoma.
Terzolo M; Angeli A; Fassnacht M; Daffara F; Tauchmanova L; Conton PA; Rossetto R; Buci L; Sperone P; Grossrubatscher E; Reimondo G; Bollito E; Papotti M; Saeger W; Hahner S; Koschker AC; Arvat E; Ambrosi B; Loli P; Lombardi G; Mannelli M; Bruzzi P; Mantero F; Allolio B; Dogliotti L; Berruti A
N Engl J Med; 2007 Jun; 356(23):2372-80. PubMed ID: 17554118
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma.
Fassnacht M; Hahner S; Polat B; Koschker AC; Kenn W; Flentje M; Allolio B
J Clin Endocrinol Metab; 2006 Nov; 91(11):4501-4. PubMed ID: 16895957
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T
Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757
[TBL] [Abstract][Full Text] [Related]
11. Adrenocortical carcinoma.
Decker RA; Kuehner ME
Am Surg; 1991 Aug; 57(8):502-13. PubMed ID: 1928992
[TBL] [Abstract][Full Text] [Related]
12. An eleven-year experience with adrenocortical carcinoma.
Pommier RF; Brennan MF
Surgery; 1992 Dec; 112(6):963-70; discussion 970-1. PubMed ID: 1455321
[TBL] [Abstract][Full Text] [Related]
13. Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers.
Fassnacht M; Johanssen S; Fenske W; Weismann D; Agha A; Beuschlein F; Führer D; Jurowich C; Quinkler M; Petersenn S; Spahn M; Hahner S; Allolio B;
J Clin Endocrinol Metab; 2010 Nov; 95(11):4925-32. PubMed ID: 20668036
[TBL] [Abstract][Full Text] [Related]
14. Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer.
Vassilopoulou-Sellin R; Guinee VF; Klein MJ; Taylor SH; Hess KR; Schultz PN; Samaan NA
Cancer; 1993 May; 71(10):3119-23. PubMed ID: 8490842
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and mitotane treatment of adrenocortical cancer. Two decades of experience from an institutional case series.
Tőke J; Uhlyarik A; Lohinszky J; Stark J; Huszty G; Micsik T; Borka K; Reismann P; Horányi J; Igaz P; Tóth M
Front Endocrinol (Lausanne); 2022; 13():952418. PubMed ID: 36246926
[TBL] [Abstract][Full Text] [Related]
16. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
17. Systemic treatment of adrenocortical carcinoma in children: data from the German GPOH-MET 97 trial.
Redlich A; Boxberger N; Strugala D; Frühwald MC; Leuschner I; Kropf S; Bucsky P; Vorwerk P
Klin Padiatr; 2012 Oct; 224(6):366-71. PubMed ID: 23143764
[TBL] [Abstract][Full Text] [Related]
18. Mitotane treatment for adrenocortical carcinoma: an overview.
De Francia S; Ardito A; Daffara F; Zaggia B; Germano A; Berruti A; Di Carlo F
Minerva Endocrinol; 2012 Mar; 37(1):9-23. PubMed ID: 22382612
[TBL] [Abstract][Full Text] [Related]
19. [Adrenal carcinoma. Clinical and anatomopathological prognostic factors].
Boneschi M; Erba M; Beretta L; Miani S; Bortolani EM
Minerva Chir; 1998 Mar; 53(3):167-72. PubMed ID: 9617113
[TBL] [Abstract][Full Text] [Related]
20. Adrenocortical tumors in children.
Ciftci AO; Senocak ME; Tanyel FC; Büyükpamukçu N
J Pediatr Surg; 2001 Apr; 36(4):549-54. PubMed ID: 11283875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
